However, biallelic FANCM variants are suggested to cause a FA‐like cancer predisposition syndrome characterized by early onset breast cancer, chemotherapy toxicity, and chromosome fragility [7, 8, 9, 10]. This evidence concerns the gene FANCM and breast carcinoma.